← All sarcoma trials
Recruiting nowN/AAges 18 Years and up

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

Sponsor: Jonsson Comprehensive Cancer Center · NCT02701153 on ClinicalTrials.gov ↗

Conditions studied

Recurrent Adult Soft Tissue Sarcoma

What it tests

  • Conventional Surgeryprocedure
  • Hypofractionated Radiation Therapyradiation
  • Laboratory Biomarker Analysisother
  • Questionnaire Administrationother

Where it's running1 site

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California 90095

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Histologically confirmed soft tissue sarcoma of the extremity/trunk
* Intermediate or high grade sarcoma
* Resectable primary lesion (patients with pre-existing metastasis will be included if their primary is still going to be resected)
* Recurrent, any grade, no previous radiation therapy
* Karnofsky performance status (KPS) \>= 70 or Eastern Cooperative Oncology Group (ECOG) 0 - 2
* If a woman is of childbearing potential, a negative serum pregnancy test must be documented

Exclusion Criteria:

* Active treatment of a separate malignancy
* History of prior irradiation to the area to be treated
* Pre-operative chemotherapy (post-op acceptable)

Updated 2026-03-10 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.